Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer Results of the definitive SWOG S1011 phase 3 surgical trial, which also found increased ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher rate of grade 3-4 adverse events and an increased risk of death in the 90 days ...